AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr | ₹75 Cr |
What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹226 Cr |
Mar2023 | ₹173 Cr |
Mar2022 | ₹172 Cr |
Mar2021 | ₹157 Cr |
Mar2020 | ₹75 Cr |
How is Long Term Provisions of AUROBINDO PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹226 Cr | 30.67 | |
Mar2023 | ₹173 Cr | 0.54 | |
Mar2022 | ₹172 Cr | 9.34 | |
Mar2021 | ₹157 Cr | 110.29 | |
Mar2020 | ₹75 Cr | - |
Compare Long Term Provisions of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹81,001.3 Cr | -0.1% | -6.4% | 63.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,418.0 Cr | -1.2% | -4.7% | 58.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,680.0 Cr | 0.8% | 7.1% | 73.4% | Stock Analytics | |
CIPLA | ₹128,755.0 Cr | 2.7% | -2.8% | 32.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,720.0 Cr | 2.3% | -2.2% | 20.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,120.0 Cr | -0.7% | -5.6% | 69.2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -0.1% |
-6.4% |
63.5% |
SENSEX | 0.6% |
-0.8% |
25.4% |
You may also like the below Video Courses